07649995954368 7649995954PMNRASQ6139 Oncobit PM NRASQ61R Control 10rxn Oncobit PM NRASQ61 Oncobit AG CH-MF-000037436 MedEnvoy Global BV NL-AR-000024028 IVD Sınıf C IVDR 2017/746 W01060299 TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER Piyasada PM-1-04-03-2 Germany 2026-06-30T10:15:36.135Z 07649995954351 7649995954PMNRASQ6139 Oncobit PM NRASQ61R PPM 40rxn Oncobit PM NRASQ61 Oncobit AG CH-MF-000037436 MedEnvoy Global BV NL-AR-000024028 IVD Sınıf C IVDR 2017/746 W01060299 TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER Piyasada PM-1-04-03-1 Germany 2026-06-30T10:15:34.920Z 07649995954344 7649995954PMNRASQ6139 Oncobit PM NRASQ61L Control 10rxn Oncobit PM NRASQ61 Oncobit AG CH-MF-000037436 MedEnvoy Global BV NL-AR-000024028 IVD Sınıf C IVDR 2017/746 W01060299 TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER Piyasada PM-1-04-02-2 Germany 2026-06-30T10:15:28.918Z 07649995954337 7649995954PMNRASQ6139 Oncobit PM NRASQ61L PPM 40rxn Oncobit PM NRASQ61 Oncobit AG CH-MF-000037436 MedEnvoy Global BV NL-AR-000024028 IVD Sınıf C IVDR 2017/746 W01060299 TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER Piyasada PM-1-04-02-1 Germany 2026-06-30T10:15:27.732Z 07649995954320 7649995954PMNRASQ6139 Oncobit PM NRASQ61K Control 10rxn Oncobit PM NRASQ61 Oncobit AG CH-MF-000037436 MedEnvoy Global BV NL-AR-000024028 IVD Sınıf C IVDR 2017/746 W01060299 TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER Piyasada PM-1-04-01-2 Germany 2026-06-30T10:15:26.513Z 07649995954313 7649995954PMNRASQ6139 Oncobit PM NRASQ61K PPM 40rxn Oncobit PM NRASQ61 Oncobit AG CH-MF-000037436 MedEnvoy Global BV NL-AR-000024028 IVD Sınıf C IVDR 2017/746 W01060299 TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER Piyasada PM-1-04-01-1 Germany 2026-06-30T10:15:25.330Z 07649995954306 7649995954PMGNAQQ209RC Oncobit PM GNAQ209P Control 10rxn Oncobit PM GNAQQ209 Oncobit AG CH-MF-000037436 MedEnvoy Global BV NL-AR-000024028 IVD Sınıf C IVDR 2017/746 W01060299 TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER Piyasada PM-1-03-02-2 Germany 2026-06-30T10:15:19.328Z 07649995954290 7649995954PMGNAQQ209RC Oncobit PM GNAQ209P PPM 40rxn Oncobit PM GNAQQ209 Oncobit AG CH-MF-000037436 MedEnvoy Global BV NL-AR-000024028 IVD Sınıf C IVDR 2017/746 W01060299 TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER Piyasada PM-1-03-02-1 Germany 2026-06-30T10:15:18.121Z 07649995954283 7649995954PMGNAQQ209RC Oncobit PM GNAQ209L Control 10rxn Oncobit PM GNAQQ209 Oncobit AG CH-MF-000037436 MedEnvoy Global BV NL-AR-000024028 IVD Sınıf C IVDR 2017/746 W01060299 TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER Piyasada PM-1-03-01-2 Germany 2026-06-30T10:15:16.907Z 07649995954276 7649995954PMGNAQQ209RC Oncobit PM GNAQ209L PPM 40rxn Oncobit PM GNAQQ209 Oncobit AG CH-MF-000037436 MedEnvoy Global BV NL-AR-000024028 IVD Sınıf C IVDR 2017/746 W01060299 TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER Piyasada PM-1-03-01-1 Germany 2026-06-30T10:15:15.711Z 07649995954269 7649995954PMGNA11Q20935 Oncobit PM GNA11Q209L Control 10rxn Oncobit PM GNA11Q209 Oncobit AG CH-MF-000037436 MedEnvoy Global BV NL-AR-000024028 IVD Sınıf C IVDR 2017/746 W01060299 TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER Piyasada PM-1-02-01-2 Germany 2026-06-30T10:15:09.698Z 07649995954252 7649995954PMGNA11Q20935 Oncobit PM GNA11Q209L PPM 40rxn Oncobit PM GNA11Q209 Oncobit AG CH-MF-000037436 MedEnvoy Global BV NL-AR-000024028 IVD Sınıf C IVDR 2017/746 W01060299 TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER Piyasada PM-1-02-01-1 Germany 2026-06-30T10:15:08.508Z 07649995954245 7649995954PMSF3B1R6257D Oncobit PM SF3B1R625H Control 10rxn Oncobit PM SF3B1R625 Oncobit AG CH-MF-000037436 MedEnvoy Global BV NL-AR-000024028 IVD Sınıf C IVDR 2017/746 W01060299 TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER Artık piyasada değil PM-1-05-02-2 Germany 2026-06-30T10:15:07.300Z 07649995954238 7649995954PMSF3B1R6257D Oncobit PM SF3B1R625H PPM 40rxn Oncobit PM SF3B1R625 Oncobit AG CH-MF-000037436 MedEnvoy Global BV NL-AR-000024028 IVD Sınıf C IVDR 2017/746 W01060299 TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER Artık piyasada değil PM-1-05-02-1 Germany 2026-06-30T10:15:06.112Z 07649995954221 7649995954PMSF3B1R6257D Oncobit PM SF3B1R625C Control 10rxn Oncobit PM SF3B1R625 Oncobit AG CH-MF-000037436 MedEnvoy Global BV NL-AR-000024028 IVD Sınıf C IVDR 2017/746 W01060299 TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER Artık piyasada değil PM-1-05-01-2 Germany 2026-06-30T10:15:00.095Z 07649995954214 7649995954PMSF3B1R6257D Oncobit PM SF3B1R625C PPM 40rxn Oncobit PM SF3B1R625 Oncobit AG CH-MF-000037436 MedEnvoy Global BV NL-AR-000024028 IVD Sınıf C IVDR 2017/746 W01060299 TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER Artık piyasada değil PM-1-05-01-1 Germany 2026-06-30T10:14:58.908Z 07649995954207 7649995954PMBRAFIVDRTQ Oncobit PM BRAF V600D Control 10rxn Oncobit PM BRAFV600 Oncobit AG CH-MF-000037436 MedEnvoy Global BV NL-AR-000024028 IVD Sınıf C IVDR 2017/746 W01060299 TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER Piyasada PM-1-01-05-2 Germany 2026-06-30T10:14:57.696Z 07649995954191 7649995954PMBRAFIVDRTQ Oncobit PM BRAF V600D PPM 40rxn Oncobit PM BRAFV600 Oncobit AG CH-MF-000037436 MedEnvoy Global BV NL-AR-000024028 IVD Sınıf C IVDR 2017/746 W01060299 TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER Piyasada PM-1-01-05-1 Germany 2026-06-30T10:14:56.496Z 07649995954184 7649995954PMBRAFIVDRTQ Oncobit PM BRAF V600R Control 10rxn Oncobit PM BRAFV600 Oncobit AG CH-MF-000037436 MedEnvoy Global BV NL-AR-000024028 IVD Sınıf C IVDR 2017/746 W01060299 TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER Piyasada PM-1-01-03-2 Germany 2026-06-30T10:14:50.500Z 07649995954177 7649995954PMBRAFIVDRTQ Oncobit PM BRAF V600R PPM 40rxn Oncobit PM BRAFV600 Oncobit AG CH-MF-000037436 MedEnvoy Global BV NL-AR-000024028 IVD Sınıf C IVDR 2017/746 W01060299 TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER Piyasada PM-1-01-03-1 Germany 2026-06-30T10:14:49.304Z